News Hobo and Van den Brule nominated for VIVA400 Knappe Koppen

9 October 2018

In the annual VIVA400 list Willemijn Hobo, theme Cancer development and immune defense, and Judith van den Brule, theme Vascular damage, are nominated.

Willemijn Hobo and Judith van den Brule have the chance to be awarded in the category Knappe Koppen. Please vote before 6 November. The award ceremony is 15 November.

You can vote for Willemijn here.

You can vote for Judith here.

More information and other Radboudumc nominees click here (only in Dutch).
 

Related news items


A throwback to the course In the lead

18 October 2018

The RIMLS Graduate School course 'In the Lead' provides new PhD candidates with insights, tips and tricks to be at the forefront of their research and training objectives.

read more

A personal touch of Antonio Castro

18 October 2018

In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t! This week: Antonio Castro.

read more

Mark van den Boogaard received the Dr. Peter Moleman penning

18 October 2018

Last week Mark van den Boogaard received the Dr. Peter Moleman penning for best article in the field of psycho-pharmacy published in the last 2 years.

read more

UN High-Level Meeting on NCDs Oral Health Event

18 October 2018

In the context of the United Nations General Assembly 3rd High-level Meeting on NCDs, oral health was addressed during a special side event on 28 September 2018.

read more

Symposium Medical care for people with intellectual disabilities

18 October 2018

On Tuesday 4 December Esther Bakker will defend her thesis ‘A Pro-active health assessment instrument for people with intellectual disabilities – towards reducing health inequities’. Prior to her defense, a symposium will be held.

read more

Very few similarities between the brains of schizophrenia patients Research at group level says little about the individual patient

16 October 2018

Patients with a diagnosis of schizophrenia are a heterogenous group with large differences between individuals. Researchers at the Radboudumc showed that only a negligible number of identical features in the brain occur in more than two percent of patients.

read more
  • Go to